The rising trend of healthcare claims denials, as highlighted in the recent State of Claims 2024 report, presents both challenges and opportunities for orthopedic medical device companies. As denial rates increase—reaching as high as 15%—these companies are witnessing an intensified struggle among healthcare providers to secure timely payments, which can directly affect their reimbursement for medical devices. This shift signals an urgent need for orthopedic device manufacturers to collaborate closely with providers to ensure accurate billing, optimize claims submission processes, and mitigate delays. Furthermore, these changes underscore the importance of adopting advanced data analytics and automated technologies, both of which are poised to reduce claim rejections and improve financial performance. For orthopedic medical device companies, staying ahead of evolving regulatory requirements and payer policies will be crucial to ensuring smooth reimbursement and minimizing the risk of revenue disruption.
Claims denials on the rise, complicating revenue collection, survey finds (Healthcare Finance)
Denial rates have steadily increased, with providers seeing rejection rates as high ...
